title: From genomics to proteomics: new directions in molecular neuropsychiatry.
abstract: Neuropsychiatry, like many other biomedical sciences, has been revolutionized by the advances in genomic technologies over the years. The advent of PCR (polymerase chain reaction) and the sequencing of the human genome have provided invaluable insights into the molecular genetics of the various psychiatric disorders through the study of candidate genes and linkage analyses. However, biological phenotype is dictated by protein expression, which has been shown to stray from the genetic blueprint designated by the genome. Consequently, the field of proteomics has recently emerged as a powerful means of exploring protein structure, function, and expression patterns. The ability to study disease at the gene and protein levels presents a tremendous opportunity for neuropsychiatric research, particularly in terms of the potential for developing therapeutic agents for novel protein targets.
authors.affiliation: 1Center for Psychiatric and Molecular Genetics, Department of Psychiatry, SUNY Upstate Medical University, Syracuse.
authors.forename: Amy F
authors.initials: AF
authors.lastname: Eisener
authors.affiliation: 1Center for Psychiatric and Molecular Genetics, Department of Psychiatry, SUNY Upstate Medical University, Syracuse.
authors.forename: Carlos N
authors.initials: CN
authors.lastname: Pato
authors.affiliation: 1Center for Psychiatric and Molecular Genetics, Department of Psychiatry, SUNY Upstate Medical University, Syracuse.
authors.forename: Mantosh
authors.initials: M
authors.lastname: Dewan
authors.affiliation: 1Center for Psychiatric and Molecular Genetics, Department of Psychiatry, SUNY Upstate Medical University, Syracuse.
authors.forename: Michele T
authors.initials: MT
authors.lastname: Pato